Cognitive impairment and dementia in Parkinson's disease: Practical issues and management

Changes in Executive Function after Acute Bouts of Passive Cycling in Parkinson’s Disease

(2016) Angela L. Ridgel et al.   JOURNAL OF AGING AND PHYSICAL ACTIVITY

Rationale and Clinical Pearls for Primary Care Doctors Referring Patients for Deep Brain Stimulation

(2013) Daniel Martinez-Ramirez et al.   GERONTOLOGY

World Medical Association Declaration of Helsinki

(2013)   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Impact of specific executive functions on driving performance in people with Parkinson's disease

(2013) Maud Ranchet et al.   MOVEMENT DISORDERS

Driving and off-road impairments underlying failure on road testing in Parkinson's disease

(2013) Hannes Devos et al.   MOVEMENT DISORDERS

Validation of a screening battery to predict driving fitness in people with Parkinson's disease

(2013) Hannes Devos et al.   MOVEMENT DISORDERS

Nonpharmacological enhancement of cognitive function in Parkinson's disease: A systematic review

(2013) John V. Hindle et al.   MOVEMENT DISORDERS

Cognitive impairment and PD patients' capacity to consent to research

(2013) J. Karlawish et al.   NEUROLOGY

Rivastigmine as alternative treatment for refractory REM behavior disorder in Parkinson's disease

(2012) Raffaella Di Giacopo et al.   MOVEMENT DISORDERS

Donepezil in Parkinson's disease dementia: A randomized, double-blind efficacy and safety study

(2012) Bruno Dubois et al.   MOVEMENT DISORDERS

Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines

(2012) Irene Litvan et al.   MOVEMENT DISORDERS

A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease

(2012) I. H. Richard et al.   NEUROLOGY

Parkinson disease and driving: An evidence-based review

(2012) A. M. Crizzle et al.   NEUROLOGY

Randomized trial of deep brain stimulation for Parkinson disease: Thirty-six-month outcomes

(2012) F. M. Weaver et al.   NEUROLOGY

Deep-Brain Stimulation for Parkinson's Disease

(2012) Michael S. Okun   NEW ENGLAND JOURNAL OF MEDICINE

Self-regulatory practices of drivers with Parkinson's disease: Accuracy of patient reports

(2012) Alexander M. Crizzle et al.   PARKINSONISM & RELATED DISORDERS

Blind randomized controlled study of the efficacy of cognitive training in Parkinson's disease

(2011) Anna Prats París et al.   MOVEMENT DISORDERS

The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: A randomized, double-blind, placebo-controlled, multicenter study

(2011) Hasmet A. Hanagasi et al.   MOVEMENT DISORDERS

The interplay of cholinergic function, attention, and falls in Parkinson's disease

(2011) Alison Yarnall et al.   MOVEMENT DISORDERS

Effect of public deliberation on attitudes toward surrogate consent for dementia research

(2011) S. Y. H. Kim et al.   NEUROLOGY

Real-life driving outcomes in Parkinson disease

(2011) E. Y. Uc et al.   NEUROLOGY

Cognitive outcome and reliable change indices two years following bilateral subthalamic nucleus deep brain stimulation

(2011) Amy E. Williams et al.   PARKINSONISM & RELATED DISORDERS

Cognitive Rehabilitation in Parkinson’s Disease: Evidence from Neuroimaging

(2011) Cristina Nombela et al.   Frontiers in Neurology

Exercise and Parkinson’s: benefits for cognition and quality of life

(2010) K. E. Cruise et al.   ACTA NEUROLOGICA SCANDINAVICA

Impaired updating ability in drivers with Parkinson's disease

(2010) M. Ranchet et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial

(2010) Paolo Barone et al.   LANCET NEUROLOGY

Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial

(2010) Murat Emre et al.   LANCET NEUROLOGY

The impact of left prefrontal repetitive transcranial magnetic stimulation on depression in Parkinson's disease: A randomized, double-blind, placebo-controlled study

(2010) Endre Pal et al.   MOVEMENT DISORDERS

Risk factors for executive dysfunction after subthalamic nucleus stimulation in Parkinson's disease

(2010) Christine Daniels et al.   MOVEMENT DISORDERS

Pallidal stimulation in advanced Parkinson's patients with contraindications for subthalamic stimulation

(2010) Tiphaine Rouaud et al.   MOVEMENT DISORDERS

Pallidal versus Subthalamic Deep-Brain Stimulation for Parkinson's Disease

(2010) Kenneth A. Follett et al.   NEW ENGLAND JOURNAL OF MEDICINE

Tests of dorsolateral frontal function correlate with objective tests of postural stability in early to moderate stage Parkinson’s disease

(2010) Joe R. Nocera et al.   PARKINSONISM & RELATED DISORDERS

Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: The COMPARE Trial

(2009) Michael S. Okun et al.   ANNALS OF NEUROLOGY

Effects of Rivastigmine on Tremor and Other Motor Symptoms in Patients with Parkinson’s Disease Dementia

(2009) Wolfgang Oertel et al.   DRUG SAFETY

QUETIAPINE IMPROVES VISUAL HALLUCINATIONS IN PARKINSON DISEASE BUT NOT THROUGH NORMALIZATION OF SLEEP ARCHITECTURE: RESULTS FROM A DOUBLE-BLIND CLINICAL-POLYSOMNOGRAPHY STUDY

(2009) HUBERT H. FERNANDEZ et al.   INTERNATIONAL JOURNAL OF NEUROSCIENCE

Vulnerable Brains: Research Ethics and Neurosurgical Patients

(2009) Paul J. Ford   JOURNAL OF LAW MEDICINE & ETHICS

Predictors of cognitive and psychosocial outcome after STN DBS in Parkinson's Disease

(2009) H. M. M. Smeding et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial

(2009) Dag Aarsland et al.   LANCET NEUROLOGY

Randomized controlled trial of memantine in dementia associated with Parkinson's disease

(2009) Iracema Leroi et al.   MOVEMENT DISORDERS

Deep brain stimulation and cognitive functions in Parkinson's disease: A three-year controlled study

(2009) Roberta Zangaglia et al.   MOVEMENT DISORDERS

Driving under low-contrast visibility conditions in Parkinson disease

(2009) E. Y. Uc et al.   NEUROLOGY

Road safety in drivers with Parkinson disease

(2009) E. Y. Uc et al.   NEUROLOGY

Useful Field of View as a Reliable Screening Measure of Driving Performance in People With Parkinson's Disease: Results of a Pilot Study

(2009) S. Classen et al.   Traffic Injury Prevention

Older Adults’ Attitudes Toward Enrollment of Non-competent Subjects Participating in Alzheimer’s Research

(2008) Jason Karlawish et al.   AMERICAN JOURNAL OF PSYCHIATRY

Driving and neurodegenerative diseases

(2008) Ergun Y. Uc et al.   Current Neurology and Neuroscience Reports

A double-blind comparison of galantamine hydrobromide ER and placebo in Parkinson disease

(2008) J Grace et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Driving assessment in Parkinson's disease-A novel predictor of performance?

(2008) Richard Cordell et al.   MOVEMENT DISORDERS

Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: A double-blind, randomized, placebo-controlled study

(2008) David Devos et al.   MOVEMENT DISORDERS

Medical decision-making capacity in cognitively impaired Parkinson's disease patients without dementia

(2008) Roy C. Martin et al.   MOVEMENT DISORDERS

A controlled trial of antidepressants in patients with Parkinson disease and depression

(2008) M. Menza et al.   NEUROLOGY

Driving ability in Parkinson's disease: Current status of research

(2008) Ester I. Klimkeit et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS